β2Microglobulin

Amyloid Proteins: The Beta Sheet Conformation and Disease

Volumn 2, Issue , 2008, Pages 667-695

  Jahn, Thomas R ^b   Radford, Sheena E ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b NONE

Author keywords

Amyloid diseases; Clinical findings; Collagen; Macrophages; Microglobulin

Indexed keywords

EID: 84889333045     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527619344.ch26     Document Type: Chapter

References (145)

1. Westermark, P., et al. Amyloid fibril protein nomenclature-2002. Amyloid 2002, 9, 197-4.
2. 2-Microglobulin-associated amyloidosis. Nephron 1996, 72, 9-4.
3. 2-Microglobulin and amyloidosis. Nephrol Dial Transplant 2000, 15 Suppl 1, 17-24.
4. 2-microglobulin amyloid deposits in a uremic patient before chronic hemodialysis. Nephron 1991, 59, 654-4.
5. 2-Microglobulin amyloidosis in chronic renal failure. N Engl J Med 1990, 323, 1070-4.
6. Warren, D.J. and L. S. Otieno. Carpal tunnel syndrome in patients on intermittent hemodialysis. Postgrad Med J 1975, 51, 450-4.
7. Assenat, H., et al. Hemodialysis: carpal tunnel syndrome and amyloid substance. Nouv Presse Med 1980, 9, 1715.
8. 2-Microglobulin is an amyloidogenic protein in man. J Clin Invest 1985, 76, 2425-4.
9. 2-microglobulin. Biochem Biophys Res Commun 1985, 129, 701-4.
10. 2-microglobulin amyloidosis. Pathol Int 2001, 51, 1-4.
11. Davison, A.M. Amyloidosis in patients with end-stage renal failure: uremia associated or dialysis related? Contrib Nephrol 1995, 113, 92-4.
12. 2-microglobulin-derived amyloidosis: an update. Kidney Int Suppl 2001, 78, S164-S171.
13. 2-microglobulin. Fedn Proc 1976, 35, 1171-4.
14. 2-microglobulin. Proc Natl Acad Sci USA 1985, 82, 4225-4.
15. 2-microglobulin on the role of the intrachain disulfide bond. Proc Natl Acad Sci USA 1975, 72, 548-4.
16. 2-microglobulin can be refolded into a native state from ex vivo amyloid fibrils. Eur J Biochem 1998, 258, 61-4.
17. 2-microglobulin in amyloidosis in vitro. Protein Sci 2001, 10, 1775-4.
18. 2-microglobulin is not essential for the immunoglobulin fold at neutral pH, but is essential for amyloid fibril formation at acidic pH. J Biochem (Tokyo) 2002, 131, 45-4.
19. 2-microglobulin blocks the extracellular folding of a major histocompatibility complex class I heavy chain. J Biol Chem 2003, 278, 5630-4.
20. 2-microglobulin endocytic pathway in rat proximal tubule cells. Am J Physiol 1994, 267, 380-4.
21. 2-microglobulin in patients undergoing hemodialysis and in normal subjects. J Lab Clin Med 1991, 118, 153-165.
22. 2-microglobulin: the constant chain of HLA-antigens. Eur J Clin Invest 1980, 10, 293-4.
23. Vincent, C., et al. Kinetics of 125I-2-microglobulin turnover in dialysed patients. Kidney Int 1992, 42, 1434-4.
24. Koch, K.M. Dialysis-related amyloidosis. Kidney Int 1992, 41, 1416-4.
25. Keating, M.J. Chronic lymphocytic leukemia. Semin Oncol 1999, 26, 107-4.
26. 2-microglobulin in chronic hepatitis C. Dig Dis Sci 1997, 42, 762-4.
27. 2-microglobulin as a new form of amyloid protein in patients undergoing long-term hemodialysis. N Engl J Med 1986, 314, 585-4.
28. 2-microglobulin levels in dialysis arthropathy. N Engl J Med 1986, 315, 1419-1420.
29. Jadoul, M., et al. Does dialysis-related amyloidosis regress after transplantation? Nephrol Dial Transplant 1997, 12, 655-4.
30. 2-microglobulin-derived amyloidosis in patients who undergo long-term hemodialysis. Report of seven cases and review of the literature. Arch Pathol Lab Med 1994, 118, 718-4.
31. Charra, B., et al. Carpal tunnel syndrome, shoulder pain and amyloid deposits in long-term hemodialysis patients. Proc Eur Dial Transplant Ass Eur Ren Ass 1985, 21, 291-4.
32. 2-microglobulin in renal disease. J Am Soc Nephrol 1998, 9, 1723-4.
33. Bardin, T. and D. Kuntz. The arthropathy of chronic hemodialysis. Clin Exp Rheumatol 1987, 5, 379-4.
34. 2-microglobulin, bone histology, and dialysis membranes in uremic patients. Nephrol Dial Transplant 1995, 10, 1701-4.
35. 2-microglobulin amyloidosis. J Am Soc Nephrol 1996, 7, 798-804.
36. Campistol, J.M. Dialysis-related amyloidosis after renal transplantation. Semin Dial 2001, 14, 99-4.
37. 2-microglobulin amyloidosis. Semin Dial 2001, 14, 86-4.
38. 2-microglobulin amyloidosis. Nephrol Dial Transplant 1996, 11 (Suppl 2), 144-146.
39. Nelson, S. R., et al. Imaging of haemodialysis-associated amyloidosis with 123I-serum amyloid P component. Lancet 1991, 338, 335-4.
40. 2-microglobulin for scintigraphic diagnosis of amyloidosis in uraemia and haemodialysis. Eur J Biochem 2000, 267, 627-4.
41. Floege, J., et al. Imaging of dialysis-related amyloid (Aβ-amyloid) deposits with 131Iβ-2-microglobulin. Kidney Int 1990, 38, 1169-4.
42. 2-microglobulin, a preprotein of hemodialysis-associated amyloidosis. Nephron 1989, 53, 37-4.
43. Coggi, G., et al. Coexpression of intermediate filaments in normal and neoplastic human tissues: a reappraisal. Ultrastruct Pathol 1989, 13, 501-4.
44. 2-microglobulin in amyloid deposits associated with hemodialysis. Kidney Int 1989, 36, 675-4.
45. 2-microglobulin in end-stage renal disease patients. Nephrol Dial Transplant 1992, 7, 1106-4.
46. 2-microglobulin as the amyloidogenic protein in dialysisamyloidosis. Kidney Int 1996, 50, 1262-1267.
47. 2-microglobulin fibril formation and reabsorption: the role of proteolysis. Semin Dial 2001, 14, 117-4.
48. 2-microglobulin. Biochem Biophys Res Commun 1990, 168, 1223-4.
49. 2-Microglobulin and its deamidated variant, N17D form amyloid fibrils with a range of morphologies in vitro. J Mol Biol 2001, 313, 559-4.
50. 2-microglobulin. Biochem Biophys Res Commun 1985, 131, 1063-4.
51. 2-microglobulin amyloid fibrils in peripheral blood mononuclear cell culture. Am J Pathol 1992, 141, 241-4.
52. 2-microglobulin in vitro. Role of serum amyloid P component: a preliminary study. Nephron 1994, 66, 404-4.
53. Gejyo, F., et al. Apolipoprotein E and alpha 1-antichymotrypsin in dialysis-related amyloidosis. Kidney Int Suppl 1997, 62, S75-S78.
54. Hirschfield, G.M. and P. N. Hawkins. Amyloidosis: new strategies for treatment. Int J Biochem Cell Biol 2003, 35, 1608-4.
55. 2-microglobulin dialysis amyloid deposits. Nephrol Dial Transplant 1995, 10, 1672-4.
56. 2-microglobulin in hemodialysis-associated amyloidosis. Lab Invest 1993, 69, 223-4.
57. 2-microglobulin amyloid fibrils in vitro. Kidney Int 2003, 64, 1080-1088.
58. 2-microglobulin amyloid fibrils. Kidney Int 1997, 52, 1543-4.
59. Argiles, A., et al. High-molecular-mass proteins in haemodialysis-associated amyloidosis. Clin Sci (Lond) 1989, 76, 547-4.
60. 2-microglobulin complex in hemodialysis patients. Kidney Int 2003, 64, 2244-4.
61. 2-microglobulin and advanced glycation end products in the development of dialysis-related amyloidosis. Kidney Int 1997, 51, 1514-4.
62. 2-microglobulin amyloidosis. Semin Dial 2001, 14, 127-4.
63. 2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis. Proc Natl Acad Sci USA 1996, 93, 2353-4.
64. Miyata, T., et al. Relevance of oxidative and carbonyl stress to long-term uremic complications. Kidney Int Suppl 2000, 76, 5120-4.
65. 2-microglobulin is modified with imidazolone, a novel advanced glycation end product, in dialysis-related amyloidosis. Kidney Int 1997, 51, 187-4.
66. Degenhardt, T. P., et al. Technical note. The serum concentration of the advanced glycation end-product N-ε-(car boxymethyl)lysine is increased in uremia. Kidney Int 1997, 52, 1064-4.
67. Niwa, T. Dialysis-related amyloidosis: pathogenesis focusing on AGE modification. Semin Dial 2001, 14, 123-4.
68. 2-microglobulin amyloidosis and clues for its histogenesis. Kidney Int 1999, 55, 1983-4.
69. 2-microglobulin amyloid deposition in the vertebral column. Kidney Int 1992, 41, 1646-4.
70. 2-microglobulin in dialysis amyloidosis. J Nephrol 2000, 13, 129-4.
71. 2-Microglobulin modified with advanced glycation end products delays monocyte apoptosis. Kidney Int 2001, 59, 990-4.
72. 2-microglobulin amyloidosis: role of monocytes/macrophages. Semin Dial 2001, 14, 135-4.
73. 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-α and interleukin-1. J Clin Invest 1994, 93, 521-4.
74. 2-microglobulin with human mononuclear phagocytes via an oxidantsensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis. J Clin Invest 1996, 98, 1088-4.
75. Matsuo, K., et al. Transforming growth factor-β is involved in the pathogenesis of dialysis-related amyloidosis. Kidney Int 2000, 57, 697-4.
76. Witko-Sarsat, V., et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996, 49, 1304-4.
77. 2-microglobulin amyloidosis. Virchows Arch 1996, 428, 37-4.
78. 2-microglobulin-induced expression of VCAM-1 and COX-2 in synovial fibroblasts. Kidney Int 2002, 61, 414-4.
79. Crofford, L. J. COX-2 in synovial tissues. Osteoarthritis Cartilage 1999, 7, 406-4.
80. 2-microglobulin induces MMP-1 but not TIMP-1 expression in human synovial fibroblasts. Kidney Int 2000, 57, 2023-4.
81. 2-microglobulin in synovial fibroblasts and macrophages. Nephrol Dial Transplant 2003, 18, 46-4.
82. 2-microglobulin amyloidosis. Semin Dial 2001, 14, 107-112
83. van Ypersele, C. and T. E. Drueke. Dialysis Amyloid. Oxford University Press, Oxford, 1996.
84. 2-microglobulin amyloidosis: effect of ESRF treatment modality and dialysis membrane type. Nephrol Dial Transplant 1996, 11 (Suppl 2), 147-149.
85. 2-microglobulin. Long-term clinical observations. Nephrol Dial Transplant 2000, 15 (Suppl 1), 49-54.
86. 2-microglobulin adsorption column. Artif Organs 2004, 28, 371-4.
87. 2-microglobulin adsorption column on dialysis-related amyloidosis. Kidney Int 2003, 64, 1522-1528.
88. 2-microglobulin in ESRD: an in-depth review. Adv Renal Replace Ther 2003, 10, 279-4.
89. Naiki, H., et al. Establishment of a kinetic model of dialysis-related amyloid fibril extension in vitro. Amyloid 1997, 4, 223-4.
90. 2-microglobulin and amyloid formation in vitro. Biochemistry 2000, 39, 8735-4.
91. 2-microglobulin is significantly populated under physiological conditions and involved in fibrillogenesis. J Biol Chem 2001, 276, 46714-46721.
92. Morgan, C. J., et al. Kidney dialysis-associated amyloidosis: a molecular role for copper in fibre formation. J Mol Biol 2001, 309, 339-4.
93. 2-microglobulin facilitates protein aggregation and fibril formation. Protein Sci 2000, 9, 831-4.
94. 2-microglobulinrelated amyloid fibrils at a neutral pH. J Am Soc Nephrol 2004, 15, 126-4.
95. 2-microglobulin in amyloid formation at neutral pH. J Mol Biol 2003, 330, 935-4.
96. 2-microglobulin amyloid in vitro revealed by atomic force microscopy. J Mol Biol 2003, 330, 785-4.
97. 2-microglobulin amyloid formation. J Mol Biol 2003, 330, 943-954.
98. 2-microglobulin. Amyloid 2001, 8, 30-4.
99. Rochet, J. C. and P.T. Lansbury, Jr. Amyloid fibrillogenesis: themes and variations. Curr Opin Struct Biol 2000, 10, 60-4.
100. Lashuel, H.A., et al. Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature 2002, 418, 291.
101. Bonar, L., et al. Characterization of the amyloid fibril as a cross-β protein. Proc Soc Exp Biol Med 1969, 131, 1373-1375.
102. Chien, P., et al. Emerging principles of conformation-based prion inheritance. Annu Rev Biochem 2004, 73, 617-4.
103. 2-microglobulin amyloid fibrils by dimethylsulfoxide. J Biochem (Tokyo) 2003, 134, 159-4.
104. 2-microglobulin in amyloid fibril formation. Biochemistry 2003, 42, 13536-4.
105. Myers, S. L., Ashcroft, A. E. and Radford, S. E. Unpublished results.
106. 2-microglobulin. Protein Sci 2002, 11, 2362-4.
107. 2-microglobulin amyloid fibril by H/D exchange. Nat Struct Biol 2002, 9, 332-4.
108. 2-microglobulin amyloid fibrils as revealed by H/D exchange. J Mol Biol 2004, 338, 559-4.
109. 2-microglobulin in amyloid fibrils. Kidney Int 2000, 57, 349-4.
110. 2-microglobulin. Nat Struct Biol 2002, 9, 326-4.
111. 2-microglobulin analysed by reduction and reoxidation of the disulfide bond. J Biochem (Tokyo) 2003, 133, 731-4.
112. 2-microglobulin studied by heteronuclear NMR. Protein Sci 2002, 11, 2218-4.
113. 2-Microglobulin amyloidosis: insights from conservation analysis and fibril modelling by protein docking techniques. J Mol Biol 2003, 330, 159-4.
114. 2-microglobulin reveals clues to its amyloidogenic properties. Proc Natl Acad Sci USA 2002, 99, 9771-4.
115. Platt, G.W., McParland, V. J., Kalverda, A. P., Homans, S.W. and Radford, S. E. J Mol Biol 2005, 346, 279-4.
116. Ban, T., et al. Direct observation of amyloid fibril growth monitored by thioflavin T fluorescence. J Biol Chem 2003, 278, 16462-4.
117. 2-microglobulin reveals the prodromes of its amyloid transition. Protein Sci 2002, 11, 487-4.
118. Berman, H.M., et al. The Protein Data Bank and the challenge of structural genomics. Nat Struct Biol 2000, 7 (Suppl), 957-959.
119. 2-microglobulin in solution. Biochemistry 1992, 31, 8906-4.
120. Siepen, J. A., et al. β-Edge strands in protein structure prediction and aggregation. Protein Sci 2003, 12, 2348-4.
121. Richardson, J. S. and D. C. Richardson. Natural β-sheet proteins use negative design to avoid edge-to-edge aggregation. Proc Natl Acad Sci USA 2002, 99, 2754-4.
122. 2-microglobulin by Achromobacter protease I. J Biol Chem 2002, 277, 1310-4.
123. 2-microglobulin under physiological conditions. J Biol Chem 2004, 279, 10814-4.
124. 2-microglobulin-insights into the mechanism of fibril formation in vitro. J Mol Biol 2003, 325, 249-257
125. de la Paz, M.L. and L. Serrano. Sequence determinants of amyloid fibril formation. Proc Natl Acad Sci USA 2004, 101, 87-4.
126. Aggeli, A., et al. Responsive gels formed by the spontaneous self-assembly of peptides into polymeric β-sheet tapes. Nature 1997, 386, 259-4.
127. 2-microglobulin uncovered quantitatively by electrospray ionization mass spectrometry. J Biol Chem 2004, 279, 27069-4.
128. Jahn, T. R., Homans, S.W. and Radford, S. E.Unpublished results.
129. Uversky, V.N. and A. L. Fink. Conformational constraints for amyloid fibrillation: the importance of being unfolded. Biochim Biophys Acta 2004, 1698, 131-4.
130. 2-microglobulin and its variants. Protein Eng 2003, 16, 561-4.
131. 2-microglobulin at neutral pH. J Biol Chem 2001, 276, 32657-4.
132. 2-microglobulin partially attains a conformation that has amyloidogenic features. J Biol Chem 2002, 277, 11184-11189.
133. 2-microglobulin. J Biol Chem 2003, 278, 47016-4.
134. 2-microglobulin. J Mol Biol 2001, 307, 379-4.
135. Capanni, C., et al. Investigation of the effects of copper ions on protein aggregation using a model system. Cell Mol Life Sci 2004, 61, 982-4.
136. Thomson, N. M., et al. Comparison of trace elements in peritoneal dialysis, hemodialysis, and uremia. Kidney Int 1983, 23, 9-4.
137. 2-microglobulin. Biochemistry 2002, 41, 10646-4.
138. 2-microglobulin upon copper binding: a possible role for copper in dialysis-related amyloidosis. Protein Sci 2004, 13, 797-809.
139. 2-microglobulin. Electrophoresis 2002, 23, 918-4.
140. 2-microglobulin and amyloidogenesis. J Biol Chem 2004, 279, 9176-4.
141. 2-microglobulin H31Y variant 3D structure highlights the protein natural propensity towards intermolecular aggregation. J Mol Biol 2004, 335, 1051-4.
142. 2-microglobulin. Biochemistry 2004, 43, 7808-4.
143. 2-microglobulin in chronic renal failure. ASAIO Trans 1988, 34, 196-4.
144. Siebold, C., et al. Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy. Proc Natl Acad Sci USA 2004, 101, 1999-4.
145. DeLano, W. The PyMOL Molecular Graphics System. DeLano Scientific, San Carlos, CA, 2002.